Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation

Transplantation

Volumn 92, Issue 10, 2011, Pages

  Lane, James T ^a   Odegaard, David E ^a   Haire, Claire E ^a   Collier, Dean S ^b   Wrenshall, Lucile E ^a   Stevens, R Brian ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C; RAPAMYCIN; SITAGLIPTIN; TACROLIMUS;

ABDOMINAL DISCOMFORT; ADULT; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEADACHE; HUMAN; HYPOGLYCEMIA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; LOOSE FECES; LOW DRUG DOSE; MALE; NAUSEA; NEW ONSENT DIABETES AFTER TRANSPLANTATION; NEW ONSET DIABETES AFTER TRANSPLANTATION; PILOT STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

DIABETES MELLITUS; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PYRAZINES; TRIAZOLES;

EID: 80855156776     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182347ea4     Document Type: Letter

References (8)

1. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Transplantation 2003; 75: SS3.
2. Sulanc E, Lane J, Puumala S, et al. New-onset diabetes after kidney transplantation: An application of 2003 International Guidelines. Transplantation 2005; 80: 945.
3. Luan F, Samaniego M. Transplantation in diabetic kidney failure patients: Modalities, outcomes, and clinical management. Semin Dial 2010; 23: 198.
4. Sharif A, Baboolal K. Risk factors for newonset diabetes after kidney transplant. Nat Rev Nephrol 2010; 6: 415.
5. Drucker D. The biology of incretin hormones. Cell Metab 2006; 3: 153.
6. Aschner P, Kipnes M, Lunceford J, et al. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type2diabetes. DiabetesCare2006; 29: 2632.
7. Stevens R, Mercer D, Grant W, et al. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: An interim report. Transplantation 2008; 85: 1391.
8. Dhillon S. Sitagliptin: A review of its use in the management of type 2 diabetes mellitus. Drugs 2010; 70: 490.